Biotech Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase) June 28, 2026
Biotech Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis June 27, 2026
Biotech Pendulum Therapeutics Appoints Madison Reed Founder and CEO Amy Errett to Board of Directors June 26, 2026
Biotech Rare Neurological Disease Treatment Market to Reach USD 43.7 Billion by 2036 as Orphan Drug Approvals and Genetic Diagnostics Expand Specialist Care | Future Market Insights June 25, 2026
Biotech WuXi Biologics’ 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations June 24, 2026
Biotech Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits June 22, 2026
Biotech CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization June 21, 2026
Biotech SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters’ Option to Purchase Additional Shares June 20, 2026